Arcadia Biosciences, Inc. (RKDA)
0.4726
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.4653
-0.01
(-1.54%)
After-Hours: 20:00
Arcadia Biosciences Total Liabilities (Quarterly) : 5.26M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.26M |
| March 31, 2026 | 2.438M |
| December 31, 2025 | 2.406M |
| September 30, 2025 | 3.141M |
| June 30, 2025 | 3.255M |
| March 31, 2025 | 4.085M |
| December 31, 2024 | 7.294M |
| September 30, 2024 | 5.092M |
| June 30, 2024 | 5.803M |
| March 31, 2024 | 5.563M |
| December 31, 2023 | 7.002M |
| September 30, 2023 | 8.068M |
| June 30, 2023 | 9.068M |
| March 31, 2023 | 13.72M |
| December 31, 2022 | 8.022M |
| September 30, 2022 | 9.455M |
| June 30, 2022 | 8.24M |
| March 31, 2022 | 8.557M |
| December 31, 2021 | 12.72M |
| September 30, 2021 | 19.00M |
| June 30, 2021 | 28.12M |
| March 31, 2021 | 25.10M |
| December 31, 2020 | 18.80M |
| September 30, 2020 | 21.88M |
| June 30, 2020 | 24.16M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.02M |
| December 31, 2019 | 24.25M |
| September 30, 2019 | 23.07M |
| June 30, 2019 | 17.06M |
| March 31, 2019 | 21.32M |
| December 31, 2018 | 11.21M |
| September 30, 2018 | 14.30M |
| June 30, 2018 | 23.00M |
| March 31, 2018 | 21.93M |
| December 31, 2017 | 8.563M |
| September 30, 2017 | 8.311M |
| June 30, 2017 | 33.67M |
| March 31, 2017 | 34.28M |
| December 31, 2016 | 34.38M |
| September 30, 2016 | 34.08M |
| June 30, 2016 | 34.42M |
| March 31, 2016 | 34.63M |
| December 31, 2015 | 34.02M |
| September 30, 2015 | 36.14M |
| June 30, 2015 | 37.06M |
| March 31, 2015 | 26.72M |
| December 31, 2014 | 26.77M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | 3.826M |
| PMGC Holdings, Inc. | 19.83M |
| Archer-Daniels-Midland Co. | 29.66B |
| Alico, Inc. | 93.83M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.893M |
| Shareholders Equity (Quarterly) | 0.633M |
| Current Ratio | 3.487 |
| Net Debt Paydown Yield | 0.28% |